Double Medical: Shareholders holding more than 5% of shares have reduced their holdings to reach an integer multiple of 1%

Double Medical announced that its shareholder, Double International, reduced its holdings by 1.968 million shares through block trading on October 31, 2025, accounting for 0.48% of the total share capital. Before this reduction, Double International held 82.9269 million shares, accounting for 20.03%; after the reduction, it held 80.9589 million shares, with the proportion dropping to 19.55%. The combined shareholding ratio with its concerted actors decreased from 84.24% to 83.77%, reaching a whole number multiple of 1%. This reduction is consistent with the previously disclosed plan, and the reduction plan has not yet been fully implemented

The medical consumables sector has undergone significant adjustments, with SINOMED hitting the limit down

The medical consumables sector has undergone significant adjustments, with SINOMED hitting the limit down, and Tianyi Medical, Double Medical, Guoke Hengtai, ZHYL, Jet Bio-Filtration, and NANFANG MEDICAL also following suit

Double Medical: Net profit in the third quarter was 180 million yuan, a year-on-year increase of 77.49%

Double Medical announced that its revenue for the third quarter was 666 million yuan, a year-on-year increase of 17.82%; net profit was 180 million yuan, a year-on-year increase of 77.49%. Revenue for the first three quarters was 1.876 billion yuan, a year-on-year increase of 22.69%; net profit was 425 million yuan, a year-on-year increase of 77.03%

The A-share medical device sector fluctuated and rose, with Allgens and United Imaging Healthcare increasing by over 10%. SONOSCAPE, MGI, Double Medical, Tinavi, and Mindray also followed suit

Double Medical: Shareholder Double International plans to reduce its holdings by no more than 2% of the company's shares

Double Medical announced that its shareholder, Double International, plans to reduce its holdings in the company by no more than 8,280,390 shares through centralized bidding or block trading within three months after the announcement date, accounting for 2.00% of the company's current total share capital, and 2.04% of the total share capital after excluding the shares repurchased in special accounts. During the implementation period of the reduction plan, if the company undergoes changes in shares such as stock dividends, capital reserve transfers to increase share capital, issuance of new shares, or rights issues, the number of shares intended for reduction will be adjusted accordingly